HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax. (Q38724542)

5 September 2017

HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax. (English)

1 reference

Human T-lymphotropic virus 1

5 September 2017

0 references

1 reference

Satomi Ando

1

1 reference

5 September 2017

Atsuhiko Hasegawa

2

1 reference

5 September 2017

Yuji Murakami

3

1 reference

5 September 2017

Na Zeng

4

1 reference

5 September 2017

Natsuko Takatsuka

5

1 reference

5 September 2017

Yasuhiro Maeda

6

1 reference

5 September 2017

Takao Masuda

7

1 reference

5 September 2017

Youko Suehiro

8

1 reference

5 September 2017

Mari Kannagi

9

1 reference

5 September 2017

language of work or name

English

0 references

publication date

23 December 2016

1 reference

5 September 2017

Journal of Immunology

1 reference

5 September 2017

198

1 reference

5 September 2017

3

1 reference

5 September 2017

1210-1219

1 reference

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

5 September 2017

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Tumor immunity against adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

HTLV-1 infection: role of CTL efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Dendritic-cell-based therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Autologus dendritic cell vaccine for chronic hepatitis B carriers: a pilot, open label, clinical trial in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Adult T-cell leukemia: a review of epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Therapeutic potential of oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1601557

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1601557

1 reference

5 September 2017

1 reference